Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $513.88 USD
Change Today -2.12 / -0.41%
Volume 771.5K
REGN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Munich
As of 8:10 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

REGN

Industry Average

Ratio data TTM as of 03/31/2015

Profitability - regeneron pharmaceuticals (REGN)

Return on Assets

Industry Comparison
15.59%

Return on Equity

Industry Comparison
13.73%

Return on Capital

Industry Comparison
18.80%

Margin Analysis - regeneron pharmaceuticals (REGN)

Gross Margin

Industry Comparison
48.67%

Levered Free Cash Flow Margin

Industry Comparison
15.54%

EBITDA Margin

Industry Comparison
32.24%

SG&A Margin

Industry Comparison
18.30%

Asset Turnover - regeneron pharmaceuticals (REGN)

Total Assets Turnover

Industry Comparison
0.8x

Accounts Receivables Turnover

Industry Comparison
2.6x

Fixed Assets Turnover

Industry Comparison
3.6x

Inventory Turnover

Industry Comparison
14.3x

Credit Ratios - regeneron pharmaceuticals (REGN)

Current Ratio

Industry Comparison
4.3x

Quick Ratio

Industry Comparison
3.9x

Long-Term Solvency - regeneron pharmaceuticals (REGN)

Total Debt/Equity

Industry Comparison
15.90%

Total Liabilities/Total Assets

Industry Comparison
29.23%

Growth Over Prior Year - regeneron pharmaceuticals (REGN)

Total Revenue

Industry Comparison
33.73%

Tangible Book Value

Industry Comparison
34.38%

EBITDA

Industry Comparison
17.31%

Gross Profit

Industry Comparison
29.21%

Receivables

Industry Comparison
27.78%

Inventory

Industry Comparison
54.67%

Diluted EPS Before Extra

Industry Comparison
-11.41%

Capital Expenditures

Industry Comparison
91.23%

Cash From Ops.

Industry Comparison
9.29%

Levered Free Cash Flow

Industry Comparison
7.59%
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
REGN:US $513.88 USD -2.12

REGN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
BioMarin Pharmaceutical Inc $127.19 USD +0.31
Incyte Corp $107.69 USD -0.72
Pharmacyclics Inc $261.25 USD +1.70
UCB SA €64.54 EUR +2.00
Vertex Pharmaceuticals Inc $125.08 USD +0.03
View Industry Companies
 

Industry Analysis

REGN

Industry Average

Valuation REGN Industry Range
Price/Earnings 100.0x
Price/Sales 17.1x
Price/Book 17.7x
Price/Cash Flow 149.2x
TEV/Sales 16.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REGENERON PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.